PL2423315T3 - Sposób osiągania lepszej ekspresji polipeptydu - Google Patents

Sposób osiągania lepszej ekspresji polipeptydu

Info

Publication number
PL2423315T3
PL2423315T3 PL11163033T PL11163033T PL2423315T3 PL 2423315 T3 PL2423315 T3 PL 2423315T3 PL 11163033 T PL11163033 T PL 11163033T PL 11163033 T PL11163033 T PL 11163033T PL 2423315 T3 PL2423315 T3 PL 2423315T3
Authority
PL
Poland
Prior art keywords
polypeptide expression
achieving improved
improved polypeptide
achieving
expression
Prior art date
Application number
PL11163033T
Other languages
English (en)
Inventor
Johannes Andries Roubos
Van Noël Nicolaas Maria Elisabeth Peij
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of PL2423315T3 publication Critical patent/PL2423315T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
    • C12N9/242—Fungal source
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C12N9/92—Glucose isomerase (5.3.1.5; 5.3.1.9; 5.3.1.18)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL11163033T 2006-06-29 2007-06-15 Sposób osiągania lepszej ekspresji polipeptydu PL2423315T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06076328 2006-06-29
EP07765439A EP2035561A1 (en) 2006-06-29 2007-06-15 A method for achieving improved polypeptide expression
EP11163033.1A EP2423315B1 (en) 2006-06-29 2007-06-15 A method for achieving improved polypeptide expression

Publications (1)

Publication Number Publication Date
PL2423315T3 true PL2423315T3 (pl) 2015-06-30

Family

ID=37199000

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11163033T PL2423315T3 (pl) 2006-06-29 2007-06-15 Sposób osiągania lepszej ekspresji polipeptydu

Country Status (12)

Country Link
US (2) US8812247B2 (pl)
EP (2) EP2035561A1 (pl)
JP (1) JP5250850B2 (pl)
CN (1) CN101490262B (pl)
AU (1) AU2007263880A1 (pl)
BR (1) BRPI0713795B1 (pl)
CA (1) CA2657975A1 (pl)
DK (1) DK2423315T3 (pl)
EA (1) EA015925B1 (pl)
ES (1) ES2534282T3 (pl)
PL (1) PL2423315T3 (pl)
WO (1) WO2008000632A1 (pl)

Families Citing this family (134)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10260805A1 (de) * 2002-12-23 2004-07-22 Geneart Gmbh Verfahren und Vorrichtung zum Optimieren einer Nucleotidsequenz zur Expression eines Proteins
US20090208480A1 (en) * 2006-08-04 2009-08-20 Yue Huang Long half-life recombinant butyrylcholinesterase
EA018840B1 (ru) 2007-02-15 2013-11-29 ДСМ АйПи АССЕТС Б.В. Рекомбинантная клетка-хозяин для получения соединения, представляющего интерес
WO2009005564A2 (en) * 2007-06-29 2009-01-08 The Regents Of The University Of California Cellulose- and hemicellulose-degradation enzyme -encoding nucleotide sequences with refined translational kinetics and methods of making same
WO2009030254A1 (en) * 2007-09-04 2009-03-12 Curevac Gmbh Complexes of rna and cationic peptides for transfection and for immunostimulation
ATE555203T1 (de) 2007-11-20 2012-05-15 Dsm Ip Assets Bv Dicarbonsäureproduktion in eukaryonten
WO2009065777A1 (en) 2007-11-20 2009-05-28 Dsm Ip Assets B.V. Dicarboxylic acid production in a filamentous fungus
US20110104771A1 (en) * 2008-02-15 2011-05-05 Rene Verwall Process for the production of a dicarboxylic acid
EP2250262B1 (en) * 2008-03-07 2015-07-29 DSM IP Assets B.V. A pentose sugar fermenting cell
WO2009109634A1 (en) * 2008-03-07 2009-09-11 Dsm Ip Assets B.V. A pentose sugar fermenting cell
TW202306945A (zh) 2008-03-11 2023-02-16 美商吉諾瑪蒂卡股份有限公司 由α-酮庚二酸製備6-胺己酸之技術
AU2009224087B2 (en) 2008-03-11 2015-04-16 Genomatica, Inc. Adipate ester or thioester synthesis
EP2123768A1 (en) 2008-05-20 2009-11-25 DSM IP Assets B.V. Preparation of (Z)-6,7-dihydro-1H-azepin-2(5H)-one
EP2123767A1 (en) 2008-05-20 2009-11-25 DSM IP Assets B.V. Preparation of epsilon-caprolactam via lysine cyclisation
WO2010003728A1 (en) 2008-07-08 2010-01-14 Dsm Ip Assets B.V. Dicarboxylic acid production by fermentation at low ph
DK2406372T3 (da) 2009-03-10 2017-11-27 Dsm Ip Assets Bv Prægastrisk esterase og derivater deraf
CN102741421B (zh) * 2009-03-10 2015-03-25 帝斯曼知识产权资产管理有限公司 用于提高多肽产率的方法
AU2010221863A1 (en) 2009-03-11 2011-10-06 Dsm Ip Assets B.V. Preparation of adipic acid
WO2010118932A1 (en) 2009-04-15 2010-10-21 Dsm Ip Assets B.V. Dicarboxylic acid production process
EP2421986A1 (en) 2009-04-22 2012-02-29 DSM IP Assets B.V. Process for the production of a recombinant polypeptide of interest
UA108853C2 (uk) 2009-07-10 2015-06-25 Спосіб ферментації галактози
EP3293264A1 (en) 2009-07-22 2018-03-14 DSM IP Assets B.V. Improved host cell for the production of a compound of interest
JP5776907B2 (ja) 2009-07-24 2015-09-09 ディーエスエム アイピー アセッツ ビー．ブイ． Ｎ−アシル保護またはｎ−グアニジル保護１，４−ブタンジアミン前駆体を介する１，４−ブタンジアミンの調製方法
PL2470667T3 (pl) 2009-08-27 2018-04-30 Dsm Ip Assets B.V. Sposób wytwarzania kwasu dikarboksylowego na drodze fermentacji
BR112012004946A2 (pt) 2009-09-03 2015-09-01 Dsm Ip Assets Bv Composição de enzima de panificação para substituir ssl
US20120238722A1 (en) 2009-11-24 2012-09-20 Roquette Freres Sa Process for the crystallization of succinic acid
EP2336310A1 (en) 2009-12-16 2011-06-22 Isobionics B.V. Valencene synthase
CA2784861A1 (en) 2009-12-21 2011-07-14 Pharmathene, Inc. Recombinant butyrylcholinesterases and truncates thereof
JP5521236B2 (ja) * 2009-12-22 2014-06-11 独立行政法人産業技術総合研究所 発現予測装置および発現予測方法
WO2011100369A2 (en) * 2010-02-09 2011-08-18 The Trustees Of Columbia University In The City Of New York Methods for altering polypeptide expression and solubility
WO2011157717A1 (en) 2010-06-14 2011-12-22 Dsm Fine Chemicals Austria Nfg. Gmbh & Co Kg Novel polypeptides having nad(p)h oxidase activity and the use thereof
AU2011273351A1 (en) 2010-07-01 2013-01-17 Dsm Ip Assets B.V. A method for the production of a compound of interest
ES2650245T3 (es) 2010-07-14 2018-01-17 Dpx Holdings B.V. Método enzimático para aminación (R)-selectiva
EA201300325A1 (ru) 2010-09-10 2013-08-30 ДСМ АйПи АССЕТС Б.В. Получение 6-аминокапроновой кислоты из альфа-кетопимелиновой кислоты
WO2012031910A2 (en) 2010-09-10 2012-03-15 Dsm Ip Assets B.V. Method for preparing alpha-ketopimelic acid by c1-elongation
WO2012038390A1 (en) 2010-09-24 2012-03-29 Dsm Ip Assets B.V. Dicarboxylic acid production process
EP2495304A1 (en) 2010-12-03 2012-09-05 DSM IP Assets B.V. Dicarboxylic acid production in a yeast cell
WO2012089613A1 (en) 2010-12-28 2012-07-05 Dsm Ip Assets B.V. Process to increase the production of a succinyl-coa derived compound
EP2683732B1 (en) 2011-03-11 2016-08-24 DSM IP Assets B.V. Vector-host system
WO2012131059A1 (en) 2011-04-01 2012-10-04 Dsm Ip Assets B.V. Preparation of 5-formyl valeric acid from alpha-ketopimelic acid
EP2537926A1 (en) 2011-06-21 2012-12-26 Isobionics B.V. Valencene synthase
ES2616790T3 (es) 2011-07-01 2017-06-14 Dsm Ip Assets B.V. Proceso para producir ácidos dicarboxílicos empleando células fúngicas
WO2013010057A1 (en) * 2011-07-13 2013-01-17 Aemetis, Inc. Compositons and methods for the production of isoprene
WO2013007820A1 (en) 2011-07-14 2013-01-17 Dsm Ip Assets B.V. Screening method
EP2554668A1 (en) 2011-08-04 2013-02-06 DSM IP Assets B.V. A pentose sugar fermenting cell
AR087423A1 (es) 2011-08-04 2014-03-19 Dsm Ip Assets Bv Celula capaz de fermentar azucares pentosas
RU2645252C2 (ru) 2012-01-05 2018-02-19 Глюкос Финланд Ой Клетка нитчатых грибов с дефицитом протеаз и способы ее применения
EP2620496B1 (en) 2012-01-30 2015-06-03 DSM IP Assets B.V. Alpha-amylase
JP6224077B2 (ja) 2012-04-17 2017-11-01 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 改変された核酸を用いてポリペプチドを発現させるための方法
EP2852610B1 (en) 2012-05-23 2018-07-11 Glykos Finland Oy Production of fucosylated glycoproteins
US20150147365A1 (en) 2012-05-31 2015-05-28 Dsm Ip Assets B.V. Oral preparation
WO2014014339A2 (en) 2012-07-18 2014-01-23 Isobionics B.V. Rhodobacter for preparing terpenoids
JP6468561B2 (ja) 2012-07-19 2019-02-13 ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． ＡｇｓＥ欠損株
DK2877576T3 (da) * 2012-07-24 2019-08-12 Bp Corp North America Inc Xyloseisomeraser og anvendelser deraf
IN2015DN01042A (pl) 2012-08-28 2015-06-26 Dsm Ip Assets Bv
WO2014033018A1 (en) 2012-08-28 2014-03-06 Dsm Ip Assets B.V. Yeast strains engineered to produce ethanol from acetate
US20140244228A1 (en) * 2012-09-19 2014-08-28 Agency For Science, Technology And Research Codon optimization of a synthetic gene(s) for protein expression
DK2898076T3 (en) 2012-09-19 2018-06-14 Dsm Ip Assets Bv METHOD OF CELL MODIFICATION USING ESSENTIAL GENES AS MARKERS AND EVEN RECYCLING THESE
US10273507B2 (en) 2012-10-16 2019-04-30 Dsm Ip Assets B.V. Cells with improved pentose conversion
WO2014142647A1 (en) 2013-03-14 2014-09-18 Wageningen Universiteit Fungals strains with improved citric acid and itaconic acid production
SG11201600115SA (en) 2013-07-10 2016-02-26 Novartis Ag Multiple proteases deficient filamentous fungal cells and methods of use thereof
AU2014332442B2 (en) 2013-08-26 2019-12-19 Biontech Research And Development, Inc. Nucleic acids encoding human antibodies to Sialyl-Lewis
AR097480A1 (es) 2013-08-29 2016-03-16 Dsm Ip Assets Bv Células de levadura convertidoras de glicerol y ácido acético con una conversión de ácido acético mejorada
DK3077517T3 (en) 2013-12-02 2019-02-11 Dsm Ip Assets Bv ISSTRUCTURING PROTEIN
WO2015177152A1 (en) 2014-05-19 2015-11-26 Dsm Ip Assets B.V. Proline-specific endoprotease
US10450554B2 (en) 2014-05-19 2019-10-22 Dsm Ip Assets B.V. Proline specific endoprotease
WO2015177153A1 (en) 2014-05-19 2015-11-26 Dsm Ip Assets B.V. Proline-specific endoprotease
US9856324B2 (en) 2014-06-04 2018-01-02 MabVax Therapeutics, Inc. Human monoclonal antibodies to ganglioside GD2
SG11201700446XA (en) 2014-07-21 2017-02-27 Glykos Finland Oy Production of glycoproteins with mammalian-like n-glycans in filamentous fungi
WO2016110512A1 (en) 2015-01-06 2016-07-14 Dsm Ip Assets B.V. A crispr-cas system for a yeast host cell
WO2016110453A1 (en) 2015-01-06 2016-07-14 Dsm Ip Assets B.V. A crispr-cas system for a filamentous fungal host cell
US10590436B2 (en) 2015-01-06 2020-03-17 Dsm Ip Assets B.V. CRISPR-CAS system for a lipolytic yeast host cell
CN107429273A (zh) 2015-02-16 2017-12-01 帝斯曼知识产权资产管理有限公司 用于在厌氧条件下生产衣康酸的方法
AR104205A1 (es) 2015-04-09 2017-07-05 Dsm Ip Assets Bv Fosfolipasa c
WO2016193292A1 (en) 2015-06-02 2016-12-08 Dsm Ip Assets B.V. Use of ice structuring protein afp19 expressed in filamentous fungal strains for preparing food
US10724040B2 (en) 2015-07-15 2020-07-28 The Penn State Research Foundation mRNA sequences to control co-translational folding of proteins
WO2017050652A1 (en) 2015-09-25 2017-03-30 Dsm Ip Assets B.V. Asparaginase
EP4361240A3 (en) 2015-11-17 2024-07-31 DSM IP Assets B.V. Preparation of a stable beer
WO2017201731A1 (en) 2016-05-27 2017-11-30 Beijing Vdjbio Co., Ltd. Antibodies, composition and kits comprising same, and methods of use thereof
WO2017211930A1 (en) 2016-06-10 2017-12-14 Dsm Ip Assets B.V. Mutant lipase and use thereof
CN109689864B (zh) 2016-07-13 2023-04-04 帝斯曼知识产权资产管理有限公司 苹果酸脱氢酶
BR112019000430A2 (pt) 2016-07-13 2019-07-09 Dsm Ip Assets Bv sistema crispr-cas para uma célula hospedeira de algas
WO2018019948A1 (en) 2016-07-29 2018-02-01 Dsm Ip Assets B.V. Polypeptides having cellulolytic enhancing activity and uses thereof
CN106650307B (zh) * 2016-09-21 2019-04-05 武汉伯远生物科技有限公司 一种基于密码子对使用频度的基因密码子优化方法
US20200199599A1 (en) 2016-09-23 2020-06-25 Dsm Ip Assets B.V. A guide-rna expression system for a host cell
WO2018114940A1 (en) 2016-12-21 2018-06-28 Dsm Ip Assets B.V. Lipolytic enzyme variants
WO2018114938A1 (en) 2016-12-21 2018-06-28 Dsm Ip Assets B.V. Lipolytic enzyme variants
WO2018114941A1 (en) 2016-12-21 2018-06-28 Dsm Ip Assets B.V. Lipolytic enzyme variants
WO2018114912A1 (en) 2016-12-21 2018-06-28 Dsm Ip Assets B.V. Lipolytic enzyme variants
CN110088274A (zh) 2016-12-22 2019-08-02 帝斯曼知识产权资产管理有限公司 谷胱甘肽还原酶
WO2018148761A1 (en) * 2017-02-13 2018-08-16 The Regents Of The University Of Colorado, A Body Corporate Compositions, methods and uses for multiplexed trackable genomically-engineered polypeptides
NL2018457B1 (en) 2017-03-02 2018-09-21 Isobionics B V Santalene Synthase
US20200063166A1 (en) 2017-03-13 2020-02-27 Dsm Ip Assets B.V. Zinc binuclear cluster transcriptional regulator-deficient strain
CN107353327A (zh) * 2017-03-30 2017-11-17 南京百斯杰生物工程有限公司 植酸酶在黑曲霉中表达
CN110462044A (zh) 2017-04-06 2019-11-15 帝斯曼知识产权资产管理有限公司 自引导整合构建体(sgic)
CN110070913B (zh) * 2017-07-25 2023-06-27 南京金斯瑞生物科技有限公司 一种基于免疫算法的密码子优化方法
NL2019473B1 (en) 2017-09-01 2019-03-11 Isobionics B V Terpene Synthase producing patchoulol and elemol, and preferably also pogostol
CN111712568A (zh) 2017-09-26 2020-09-25 邦吉全球创新有限责任公司 从基于三酰基甘油的油酶促除去叶绿素底物
WO2019073069A1 (en) 2017-10-13 2019-04-18 Boehringer Ingelheim International Gmbh HUMAN ANTIBODIES AGAINST THOMSEN-NEW ANTIGEN (TN)
WO2019012162A2 (en) 2017-12-20 2019-01-17 Dsm Ip Assets B.V. GENOMIC EDITING METHOD IN HOST CELL
US11944104B2 (en) 2018-04-05 2024-04-02 Dsm Ip Assets B.V. Variant maltogenic alpha-amylase
CN112088215A (zh) 2018-05-09 2020-12-15 帝斯曼知识产权资产管理有限公司 Crispr瞬时表达构建体(ctec)
KR20210013585A (ko) 2018-05-18 2021-02-04 디에스엠 아이피 어셋츠 비.브이. 돌연변이체 리파아제 및 이의 용도
US20230250406A1 (en) 2018-05-18 2023-08-10 Dsm Ip Assets B.V. Mutant lipase and use thereof
BR112020025589A2 (pt) 2018-06-19 2021-03-23 Dsm Ip Assets B.V. variantes de enzima lipolítica
TWI802728B (zh) * 2018-07-30 2023-05-21 大陸商南京金斯瑞生物科技有限公司 密碼子優化方法、包括其之系統及電子裝置、其核酸分子及使用其之蛋白質表現方法
CA3105455A1 (en) * 2018-08-15 2020-02-20 Zymergen Inc. Bioreachable prediction tool with biological sequence selection
WO2020088645A1 (en) 2018-11-02 2020-05-07 Beijing Vdjbio Co., Ltd. Modified ctla4 and methods of use thereof
JP7497348B2 (ja) 2018-11-15 2024-06-10 ディーエスエム アイピー アセッツ ビー．ブイ． リボフラビンの改善された産生
US20220056460A1 (en) 2018-12-05 2022-02-24 Dsm Ip Assets B.V. Crispr guide-rna expression strategies for multiplex genome engineering
WO2020198212A1 (en) 2019-03-27 2020-10-01 Bunge Global Innovation, Llc Silica adsorbent treatment for removal of chlorophyll derivatives from triacylglycerol-based oils
MX2021011757A (es) * 2019-03-28 2021-12-10 Intellia Therapeutics Inc Polinucleótidos, composiciones y métodos para la expresión de polipéptidos.
WO2020260431A1 (en) 2019-06-28 2020-12-30 F. Hoffmann-La Roche Ag Method for the production of an antibody
EP3766982A1 (en) 2019-07-18 2021-01-20 Delft Advanced Biofuels B.V. Integrated system for biocatalytically producing and recovering an organic substance
CN110491447B (zh) * 2019-08-05 2021-08-17 浙江省农业科学院 一种用于异源基因体外表达的密码子优化方法及应用
CN110873833B (zh) * 2019-12-10 2022-04-08 国网河南省电力公司洛阳供电公司 一种含分布式电源的配电网自适应故障区段定位方法
MX2022011117A (es) 2020-03-10 2022-10-03 Dsm Ip Assets Bv Polvo lacteo reducido en lactosa.
EP4015626A1 (en) 2020-12-18 2022-06-22 Isobionics B.V. Enzymes and methods for fermentative production of monoterpene esters
JP2022155412A (ja) * 2021-03-30 2022-10-13 国立大学法人 奈良先端科学技術大学院大学 植物へ導入する遺伝子の人工配列の設計システム
EP4328311A4 (en) 2021-04-21 2025-04-30 Zhejiang University NEGATIVE-STRAND RNA VIRUS VECTOR AND PLANT GENOME EDITING WITHOUT TRANSFORMATION
WO2022263504A1 (en) 2021-06-17 2022-12-22 Dsm Ip Assets B.V. Improved bacillus host cell
JP2024528957A (ja) 2021-08-02 2024-08-01 ビーエーエスエフ ソシエタス・ヨーロピア イオニリデンエタンシンターゼによる新規な芳香化合物の生成
CN118284624A (zh) 2021-11-19 2024-07-02 米罗生物有限公司 Pd-1抗体及其用途
IL315888A (en) 2022-04-06 2024-11-01 Mirobio Ltd Transgenic CD200R antibodies and their uses
EP4525615A2 (en) 2022-05-14 2025-03-26 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections
US20250304938A1 (en) 2022-05-16 2025-10-02 Dsm Ip Assets B.V. Lipolytic enzyme variants
DE102022118459A1 (de) 2022-07-22 2024-01-25 Proteolutions UG (haftungsbeschränkt) Verfahren zur optimierung einer nukleotidsequenz für die expression einer aminosäuresequenz in einem zielorganismus
WO2024051806A1 (zh) * 2022-09-09 2024-03-14 南京金斯瑞生物科技有限公司 一种设计人源化抗体序列的方法
EP4365192A1 (en) 2022-11-04 2024-05-08 DSM IP Assets B.V. Microbial production of growth factors
WO2025012325A1 (en) 2023-07-11 2025-01-16 Dsm Ip Assets B.V. Protein arginine deiminase
WO2025099225A1 (en) 2023-11-08 2025-05-15 Dsm Ip Assets B.V. Improved enzyme variants
WO2025099224A1 (en) 2023-11-08 2025-05-15 Dsm Ip Assets B.V. Improved enzyme variants
WO2025144795A1 (en) 2023-12-28 2025-07-03 Dsm Ip Assets B.V. Cells and methods for the production of glycosylated compounds
WO2026003190A1 (en) 2024-06-27 2026-01-02 Basf Se Means and methods for alpha-farnesene production

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK122686D0 (da) 1986-03-17 1986-03-17 Novo Industri As Fremstilling af proteiner
EP0340878B1 (en) 1988-05-06 2001-05-16 Aventis Pharma S.A. Process for the biochemical oxidation of steroids and genetically engineered cells to be used therefor
CA1333777C (en) 1988-07-01 1995-01-03 Randy M. Berka Aspartic proteinase deficient filamentous fungi
US5082767A (en) * 1989-02-27 1992-01-21 Hatfield G Wesley Codon pair utilization
DE69432543T2 (de) 1993-07-23 2003-12-24 Dsm N.V., Te Heerlen Selektionmarker-genfreie rekombinante Stämme: Verfahren zur ihrer Herstellung und die Verwendung dieser Stämme
US5795737A (en) 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
CA2204257C (en) 1994-11-08 2009-01-06 Kaj Andre Holm Tripeptidyl aminopeptidase
US5874304A (en) * 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
JP4263241B2 (ja) 1996-03-27 2009-05-13 ノボザイムス アクティーゼルスカブ アルカリプロテアーゼを欠失した糸状真菌
JP5303084B2 (ja) 1997-04-11 2013-10-02 コニンクリーケ デーエスエム ナムローゼ フェンノートシャップ 工業的組み換え生物を溝築するための手段としての遺伝子変換
EP1002091B1 (en) * 1997-07-09 2012-02-29 Coridon Pty Limited Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
EP1854890A1 (en) 1997-12-22 2007-11-14 DSM IP Assets B.V. Expression cloning in filamentous fungi
AU1774000A (en) 1998-12-23 2000-07-31 Novozymes A/S Methods for producing polypeptides in aspergillus mutant cells
EP1157100B1 (en) 1999-02-22 2006-01-11 Novozymes A/S Oxaloacetate hydrolase deficient fungal host cells
DE60142226D1 (de) 2000-03-14 2010-07-08 Novozymes As Pilz transkriptionsaktivator zur verwendung in verfahren zur herstellung von polypeptiden
CA2403842C (en) 2000-03-24 2012-09-25 Genencor International, Inc. Increased production of secreted proteins by recombinant eukaryotic cells
IL156557A0 (en) * 2000-12-22 2004-01-04 Janssen Pharmaceutica Nv Bax-responsive genes for drug target identification in yeast and fungi
AU2002242025A1 (en) 2001-01-29 2002-08-12 Olga Kachurina Advanced composite ormosil coatings
EP1231272A3 (en) 2001-02-08 2002-11-13 Laboratorios Ovejero S.A. Procedure for obtaining bovine chymosin (rennin), curd
AU2003206684A1 (en) 2002-02-20 2003-09-09 Novozymes A/S Plant polypeptide production
EP1490494A1 (en) 2002-04-01 2004-12-29 Walter Reed Army Institute of Research Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell
JP2006516399A (ja) 2003-02-05 2006-07-06 デーエスエム アイピー アセッツ ベー． ヴェー． ポリペプチドを製造するためのシュウ酸欠損Ａｓｐｅｒｇｉｌｌｕｓｎｉｇｅｒ菌株の使用
JP4638418B2 (ja) 2003-03-31 2011-02-23 ノボザイムス，インコーポレイティド アスペルギラス・ニガーの酵素−欠失変異体における生物学的物質の生成方法
EP3351637B1 (en) 2004-04-02 2020-06-10 DSM IP Assets B.V. Filamentous fungal mutants with improved homologous recombination efficiency
EP1776461A2 (en) 2004-04-16 2007-04-25 DSMIP Assets B.V. Fungal promoters for expressing a gene in a fungal cell
WO2005123763A1 (en) 2004-06-16 2005-12-29 Dsm Ip Assets B.V. Production of polypeptides by improved secretion
CN101094919B (zh) 2004-10-12 2014-09-03 帝斯曼知识产权资产管理有限公司 在生产多肽的方法中有用的真菌转录活化因子
US8129143B2 (en) 2004-10-15 2012-03-06 Dsm Ip Assets B.V. Method for production of a compound in a eukaryotic cell
US7888489B2 (en) * 2005-01-24 2011-02-15 Dsm Ip Assets B.V. Method for producing a compound of interest in a filamentous fungal cell

Also Published As

Publication number Publication date
US20090286280A1 (en) 2009-11-19
US8812247B2 (en) 2014-08-19
CN101490262B (zh) 2012-09-26
DK2423315T3 (en) 2015-04-13
EP2423315B1 (en) 2015-01-07
BRPI0713795A2 (pt) 2012-11-06
EP2423315A1 (en) 2012-02-29
EP2035561A1 (en) 2009-03-18
ES2534282T3 (es) 2015-04-21
EA015925B1 (ru) 2011-12-30
JP2009540845A (ja) 2009-11-26
CA2657975A1 (en) 2008-01-03
BRPI0713795B1 (pt) 2018-03-20
WO2008000632A1 (en) 2008-01-03
AU2007263880A1 (en) 2008-01-03
EA200900096A1 (ru) 2009-06-30
CN101490262A (zh) 2009-07-22
JP5250850B2 (ja) 2013-07-31
US20140377800A1 (en) 2014-12-25

Similar Documents

Publication Publication Date Title
PL2423315T3 (pl) Sposób osiągania lepszej ekspresji polipeptydu
IL196496A (en) A method for producing recombinant protein
GB0625995D0 (en) Method for preparing a composition
ZA200904317B (en) Improved method for making analgesics
IL197221A (en) Method for cleaning up protein
IL201391A0 (en) Method for stabilizing a protein
GB0601961D0 (en) Method
GB0603081D0 (en) Method
GB0607317D0 (en) Method
GB0606147D0 (en) Method
IL197979A0 (en) Method for peptide synthesis
GB0724491D0 (en) A method
GB2456999B (en) Method for preparing 2-deoxy-L-ribose
GB0605323D0 (en) Method
GB0603008D0 (en) Method
IL193248A0 (en) A method for producing o-methyl-n-nitroisourea
GB0604018D0 (en) Method
GB0601699D0 (en) Method
GB0602986D0 (en) Method
GB0606954D0 (en) Method
GB0611391D0 (en) Method
TWI340345B (en) Method for selecting critical variables
GB0603036D0 (en) Method
GB0612014D0 (en) Method
GB0612342D0 (en) Method